Li Jing, Qiao Huimin, Yang Yang, Wu Lan, Xu Dongdong, Lin Zhongqiu, Lu Huaiwu
The Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital of Sun Yat-Sen University.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University.
Int J Surg. 2025 Jan 1;111(1):20-30. doi: 10.1097/JS9.0000000000001997.
To describe treatment patterns and prognoses for clear cell adenocarcinoma of the cervix (CCAC), a poorly understood rare tumor.
A retrospective case-control study was conducted using the Surveillance, Epidemiology, and End Results (SEER) database, focusing on females diagnosed with CCAC between 2000 and 2019. Kaplan-Meier analysis, propensity score matching, Cox regression analysis, and subgroup analysis were used to assess treatment outcomes and risk factors.
Of the 52 153 patients with cervical cancer in the SEER database, 528 had CCAC. Overall survival (OS) was worse for patients with early-stage and locally advanced CCAC disease, although no differences in survival were observed for patients with stage IVB disease compared to those with other histologies. In our investigation into treatment patterns, we have discovered that surgical treatment was the preferred choice for the majority of patients with locally advanced CCAC (58.5%). Further, Kaplan-Meier analysis revealed that surgery improved OS in CCAC patients (65.6 vs. 25.3%, P =0.000), with similar results in locally advanced-stage patients (57.9 vs. 26.7%, P =0.000). Moreover, multivariate Cox regression analysis revealed that surgery was significantly associated with a more favorable prognosis in CCAC patients with locally advanced disease (HR 0.299, 95% CI: 0.153-0.585, P =0.000). Consistent findings were observed following propensity score matching (HR 0.283, 95% CI: 0.106-0.751, P =0.011). According to the subgroup analyses, surgical intervention continued to show a beneficial effect on CCAC patients with locally advanced disease (HR=0.31, 95% CI: 0.21-0.46, P <0.001). In particular, we also found that compared to patients who received primary radiotherapy (RT), those who underwent radical surgery exhibited a significantly prolonged OS in locally advanced CCAC patients. Furthermore, multivariate Cox regression analysis revealed that surgery was associated with better outcomes in patients with stage IB3-IIA2 and locally resectable stage IIIC patients (HR 0.207, 95% CI=0.043-0.991, P =0.049). However, this trend was not observed for patients with stage IIB-IVA (except locally resectable stage IIIC) CCAC.
Surgery should be considered the preferred treatment option for patients with locally advanced CCAC at stage IB3-IIA2 and locally resectable stage IIIC.
描述宫颈透明细胞腺癌(CCAC)的治疗模式和预后,这是一种了解较少的罕见肿瘤。
使用监测、流行病学和最终结果(SEER)数据库进行了一项回顾性病例对照研究,重点关注2000年至2019年间被诊断为CCAC的女性。采用Kaplan-Meier分析、倾向评分匹配、Cox回归分析和亚组分析来评估治疗结果和危险因素。
在SEER数据库的52153例宫颈癌患者中,528例患有CCAC。早期和局部晚期CCAC疾病患者的总生存期(OS)较差,尽管IVB期疾病患者与其他组织学类型患者的生存期无差异。在我们对治疗模式的调查中,我们发现手术治疗是大多数局部晚期CCAC患者(58.5%)的首选。此外,Kaplan-Meier分析显示,手术改善了CCAC患者的OS(65.6%对25.3%,P=0.000),局部晚期患者也有类似结果(57.9%对26.7%,P=0.000)。此外,多变量Cox回归分析显示,手术与局部晚期疾病CCAC患者更有利的预后显著相关(风险比0.299,95%置信区间:0.153-0.585,P=0.000)。倾向评分匹配后观察到一致的结果(风险比0.283,95%置信区间:0.106-0.751,P=0.011)。根据亚组分析,手术干预对局部晚期疾病CCAC患者继续显示出有益效果(风险比=0.31,95%置信区间:0.21-0.46,P<0.001)。特别是,我们还发现,与接受原发放疗(RT)的患者相比,接受根治性手术的局部晚期CCAC患者的OS显著延长。此外,多变量Cox回归分析显示,手术与IB3-IIA2期和局部可切除的IIIC期患者的更好结局相关(风险比0.207,95%置信区间=0.043-0.991,P=0.049)。然而,IIB-IVA期(局部可切除的IIIC期除外)CCAC患者未观察到这种趋势。
对于IB3-IIA2期局部晚期CCAC和局部可切除的IIIC期患者,手术应被视为首选治疗方案。